- Consumer Products
- Latest 243.21
- Currency US$
- Change 4.43
- Percent Change 1.855 %
- Volume 1,695,030
- Thu Oct 30, 2014 04:04 PM EDT NYSE data delayed 15 minutes.
12 months ended Mar 31, 2014.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Aug 5||$3.37||Nov 5||$3.11|
12 months ended Oct 31, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
Actavis plc is a specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. Its business is focused principally in the Urology and Women's Health therapeutic categories, as well as Gastroenterology and Dermatology. Actavis plc, formerly known as Actavis Inc., is headquartered in Parsippany, New Jersey, USA.